Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fixed-Combination OTCs Derived From Botanicals Due For Rulemaking

This article was originally published in The Tan Sheet

Executive Summary

A proposed rule on fixed-combination OTC products derived from natural sources, including animal and botanical raw materials, could be issued by FDA as early as July, according to the agency's "unified agenda" published in the Federal Register April 24.
Advertisement

Related Content

Only 16% Of Supplement Makers Surveyed Report AEs To FDA - GMP Study
Only 16% Of Supplement Makers Surveyed Report AEs To FDA - GMP Study
Only 16% Of Supplement Makers Surveyed Report AEs To FDA - GMP Study

Topics

Advertisement
UsernamePublicRestriction

Register

PS091150

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel